SCI时时刷

search
Chapter Two - A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
Chapter Two - A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
The heterogeneity of non-motor features observed in people with Parkinson’s disease (PD) is often dominated by one or more...
Chapter Three - Insight gained from using animal models to study pain in Parkinson’s disease
Chapter Three - Insight gained from using animal models to study pain in Parkinson’s disease
Pain is one of the key non-motor symptoms experienced by a large proportion of people living with Parkinson’s disease (PD)...
Chapter Four - Investigating affective neuropsychiatric symptoms in rodent models of Parkinson’s disease
Chapter Four - Investigating affective neuropsychiatric symptoms in rodent models of Parkinson’s disease
Affective neuropsychiatric disorders such as depression, anxiety and apathy are among the most frequent non-motor symptoms...
Chapter Five - Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Chapter Five - Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting about 1% of people over 65 years ...
A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms
Available online 15 January 2024Author links open overlay panel, , , , AbstractThe heterogeneity of non-motor features obs...
Insight gained from using animal models to study pain in Parkinson’s disease
Insight gained from using animal models to study pain in Parkinson’s disease
As noted in Chapter 1, pain is one of the key non-motor symptoms experienced by more than half of those living with Parkin...
Executive dysfunction and cognitive decline, a non-motor symptom of Parkinson’s disease captured in animal models
Executive dysfunction and cognitive decline, a non-motor symptom of Parkinson’s disease captured in animal models
Parkinson’s disease (PD) is a complex and progressive neurodegenerative disorder primarily characterised by motor symptoms...
Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting about 1% of people over 65 years ...
Half Title Page
Half Title Page
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Series Page
Series Page
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Chapter One - The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence
Chapter One - The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence
Autism spectrum disorder (ASD) remains a public health concern, as recent prevalence estimates of ASD are as high as 1 in ...
Chapter Three - Involvement of brain metabolism in neurodevelopmental disorders
Chapter Three - Involvement of brain metabolism in neurodevelopmental disorders
Metabolism represents a series of biochemical pathways that provide cells with solutions to utilize and produce energy, to...
Chapter Five - Toward an understanding of the role of the exposome on fragile X phenotypes
Chapter Five - Toward an understanding of the role of the exposome on fragile X phenotypes
Fragile X syndrome (FXS) is the leading known monogenetic cause of autism with an estimated 21–50% of FXS individuals meet...
Chapter Six - How dendritic spines shape is determined by MMP-9 activity in FXS
Chapter Six - How dendritic spines shape is determined by MMP-9 activity in FXS
Fragile X syndrome (FXS) is the leading inherited intellectual disability and the most prevalent single-gene cause of auti...
Chapter Seven - Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome
Chapter Seven - Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome
Since the discovery of the genetic mutation in Fragile X Syndrome (FXS) and the resulting absence of the fragile X messeng...
How dendritic spines shape is determined by MMP-9 activity in FXS
How dendritic spines shape is determined by MMP-9 activity in FXS
Fragile X syndrome (FXS) is the leading inherited intellectual disability and the most prevalent single-gene cause of auti...
Chapter Three - Neuromodulation and quality of life for patient with spasticity after spinal cord injury
Chapter Three - Neuromodulation and quality of life for patient with spasticity after spinal cord injury
Advances of the modern medicine require reconceptualization of the existing approaches to therapy of neurological diseases...